Opportunity Information: Apply for RFA DA 15 006
Apply for RFA DA 15 006
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jun 17, 2015 and posted on Mar 27, 2014.
- Applicants must submit their applications by Jun 17, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Native American tribal governments (Federally recognized) State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply.Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2) is a National Institutes of Health (NIH) funding opportunity run through the National Institute on Drug Abuse (NIDA) that is designed to invest in the next generation of research leaders. "Avenir" means "future" in French, and the program is intentionally forward-looking: it supports early stage investigators who are proposing bold, highly innovative genetics or epigenetics research aimed at advancing the understanding of substance abuse and addiction. A central idea behind this award is that some of the most potentially transformative projects are also the ones that may not yet have the large amount of preliminary data typically expected for a traditional R01 grant. This mechanism is meant to give promising early career scientists room to pursue high-impact ideas that could reshape the field.
The scientific focus of this specific Avenir program is genetics and epigenetics as they relate to substance use, substance use disorders, and addiction-related outcomes. In practical terms, the opportunity is intended for projects that leverage genomic, genetic, and epigenomic approaches to explain risk, resilience, mechanisms, trajectories, or consequences associated with drug use and addiction. While the source text does not list examples of acceptable research topics, the program title and description indicate that proposals should be grounded in genetic or epigenetic concepts and should be positioned as innovative and potentially field-changing rather than incremental extensions of existing work. NIDA notes that it has developed two separate Avenir Award Programs, one focused on HIV/AIDS research and the other (this one) focused on genetics or epigenetics, which signals that this FOA is part of a broader strategy to stimulate high-risk, high-reward research in priority areas.
Administratively, this is a discretionary grant opportunity using the NIH DP2 funding instrument type. It falls under the broad activity categories of education and health and is associated with CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The announcement indicates there is no cost sharing or matching requirement, which means applicants are not required to contribute additional non-federal funds to be eligible or competitive based on match.
In terms of funding size and limits, the opportunity lists an estimated total funding amount of $1,500,000 and an award ceiling of $300,000. The ceiling communicates the maximum award amount expected under this announcement (as presented in the source data), and the total estimated funding suggests NIDA expected to support multiple awards depending on final budgets and the number of meritorious applications.
Eligibility is broad and includes many types of domestic organizations and governmental entities. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (both 501(c)(3) and certain non-501(c)(3) organizations), for-profit organizations (including small businesses and other for-profits), and a wide range of government bodies such as state governments, county governments, city or township governments, special district governments, and independent school districts. The eligibility language also explicitly includes a range of mission-driven and community-serving entities, such as faith-based or community-based organizations, Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Tribal organizations and tribal governments are included as eligible in multiple forms (federally recognized and other-than-federally recognized categories are referenced), and U.S. territories or possessions are also listed.
At the same time, the announcement clearly restricts foreign involvement. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. This means the applicant organization and the work structure must remain within allowable domestic boundaries as defined by NIH policy.
Key dates in the source data show the opportunity was posted on March 27, 2014, with an archive date of July 18, 2016. The record also displays multiple closing-date fields, including an "OriginalClosingDate" of August 18, 2016, a "CurrentClosingDate" associated with June 17, 2015, and a "CreationDate" of June 17, 2015, which suggests the listing may reflect updates or system record changes over time rather than a single straightforward deadline. For an applicant, the practical takeaway is that the authoritative details would be confirmed in the full announcement on the NIH Grants Guide page linked in the record (RFA-DA-15-006).
For reference and follow-up, the funding opportunity number is RFA-DA-15-006, and the official title is "Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2)." The listing provides an additional information link to the full NIH announcement and includes contact guidance directing technical access or linking issues to the NIH Office of Extramural Research (OER) webmaster (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is the Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2)?
The Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2) is an NIH funding opportunity administered by the National Institute on Drug Abuse (NIDA). It is designed to invest in early stage investigators pursuing bold, highly innovative research in genetics or epigenetics related to substance abuse and addiction.
Which NIH institute runs this program?
This opportunity is run through the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH).
What does "Avenir" mean, and why is that relevant to the program?
"Avenir" means "future" in French. The program is intentionally forward-looking and aims to support the next generation of research leaders proposing potentially transformative work.
What is the main purpose of this award?
The purpose is to support early stage investigators with high-impact, innovative genetics or epigenetics research that advances understanding of substance use, substance use disorders, and addiction-related outcomes. A key idea is to create space for high-risk, high-reward projects that may not have the large amount of preliminary data typically expected for a traditional R01 application.
What research areas does this specific Avenir program focus on?
This specific Avenir program focuses on genetics and epigenetics as they relate to substance use, substance use disorders, and addiction-related outcomes. Projects are expected to leverage genomic, genetic, and/or epigenomic approaches to explain risk, resilience, mechanisms, trajectories, or consequences associated with drug use and addiction.
Does the opportunity provide a list of example topics?
No. The provided information does not list specific example topics. However, the title and description indicate proposals should be grounded in genetics or epigenetics and positioned as innovative and potentially field-changing rather than incremental.
Is this program part of a broader NIDA Avenir strategy?
Yes. NIDA notes it developed two separate Avenir Award Programs: one focused on HIV/AIDS research and another (this one) focused on genetics or epigenetics, reflecting a broader strategy to stimulate high-risk, high-reward research in priority areas.
What is the funding instrument type for this opportunity?
The funding instrument type is NIH DP2.
What general activity categories does this opportunity fall under?
The opportunity is associated with the broad activity categories of education and health.
What is the CFDA number associated with this program?
The CFDA number listed is 93.279 (Drug Abuse and Addiction Research Programs).
Is cost sharing or matching required?
No. The announcement indicates there is no cost sharing or matching requirement.
How much total funding is estimated for this opportunity?
The opportunity lists an estimated total funding amount of $1,500,000.
What is the award ceiling (maximum award amount) listed?
The award ceiling is listed as $300,000, which indicates the maximum award amount expected under this announcement (as presented in the source data).
Does the estimated total funding amount suggest multiple awards?
Yes. The estimated total funding amount of $1,500,000 suggests NIDA expected to support multiple awards, depending on final budgets and the number of meritorious applications.
What types of organizations are eligible to apply?
Eligibility is broad and includes many types of domestic organizations and governmental entities. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (both 501(c)(3) and certain non-501(c)(3) organizations), and for-profit organizations (including small businesses and other for-profits).
Are government entities eligible to apply?
Yes. Eligible government applicants include state governments, county governments, city or township governments, special district governments, and independent school districts.
Are mission-driven and community-serving institutions included in eligibility?
Yes. The eligibility language explicitly includes entities such as faith-based or community-based organizations, Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are Tribal organizations and Tribal governments eligible?
Yes. Tribal organizations and Tribal governments are included as eligible in multiple forms, including federally recognized and other-than-federally recognized categories.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed among eligible applicant types.
Are foreign (non-U.S.) entities eligible to apply?
No. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply under this announcement.
Can a U.S. organization apply if it has a non-domestic (foreign) component?
No. Non-domestic components of U.S. organizations are not eligible to apply.
Are foreign components allowed in the project?
No. Foreign components (as defined by the NIH Grants Policy Statement) are not allowed. The applicant organization and the work structure must remain within allowable domestic boundaries as defined by NIH policy.
What is the funding opportunity number for this announcement?
The funding opportunity number is RFA-DA-15-006.
What is the official title of the funding opportunity?
The official title is "Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2)."
When was this opportunity posted?
The source data shows the opportunity was posted on March 27, 2014.
Is this opportunity archived?
Yes. The source data shows an archive date of July 18, 2016.
What closing date should applicants rely on?
The record displays multiple closing-date fields (including an OriginalClosingDate of August 18, 2016, and a CurrentClosingDate associated with June 17, 2015), suggesting the listing may reflect updates or system record changes over time rather than a single straightforward deadline. The practical takeaway is to confirm the authoritative dates and requirements in the full NIH announcement on the NIH Grants Guide page for RFA-DA-15-006.
Where can applicants find the authoritative full announcement?
The listing points to the full NIH announcement on the NIH Grants Guide page linked in the record for RFA-DA-15-006.
Who should be contacted for technical access or linking issues related to the announcement record?
The listing directs technical access or linking issues to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Natural Resource Condition Assessment at Olympic National Park
Previous opportunity: Clinical Studies of Mental Illness Not Involving Treatment Development, Efficacy, or Effectiveness Trials (Collaborative R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 15 006
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 15 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Early Phase Clinical Trials in Imaging and Image Guided Interventions (R01) Apply for PAR 14 166 Funding Number: PAR 14 166 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Physical Sciences Oncology Centers (U54) Apply for PAR 14 169 Funding Number: PAR 14 169 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) Apply for RFA DA 15 007 Funding Number: RFA DA 15 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Healthy Habits Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21) Apply for PA 14 176 Funding Number: PA 14 176 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Healthy Habits Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01) Apply for PA 14 177 Funding Number: PA 14 177 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient Provider Communication, Adherence to Treatment and Self Management (R01) Apply for PA 14 180 Funding Number: PA 14 180 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient Provider Communication, Adherence to Treatment and Self Management (R21) Apply for PA 14 181 Funding Number: PA 14 181 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01) Apply for PAR 14 184 Funding Number: PAR 14 184 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revisions to Add Biomedical Big Data Training to Active NLM Institutional Training Grants in Biomedical Informatics (T15) Apply for RFA HG 14 006 Funding Number: RFA HG 14 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Core Center of Excellence Grant Program (P30) Apply for PAR 14 186 Funding Number: PAR 14 186 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Lasker Clinical Research Scholars Program (Si2) Apply for RFA OD 14 004 Funding Number: RFA OD 14 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Information Resource Grants to Reduce Health Disparities (G08) Apply for RFA LM 14 001 Funding Number: RFA LM 14 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Wild Horse and Burro Contraception Apply for L14AS00048 Funding Number: L14AS00048 Agency: Bureau of Land Management Category: Education Health Funding Amount: $500,000 |
| Chronic Wounds Advancing the Science from Prevention to Healing (R01) Apply for RFA NR 15 001 Funding Number: RFA NR 15 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Long Term Retention in Care for U.S. Substance Using Populations (R34) Apply for PA 14 222 Funding Number: PA 14 222 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Long Term Retention in Care for U.S. Substance Using Populations (R21) Apply for PA 14 223 Funding Number: PA 14 223 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Long Term Retention in Care for U.S. Substance Using Populations (R01) Apply for PA 14 224 Funding Number: PA 14 224 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain (R01) Apply for PAR 14 225 Funding Number: PAR 14 225 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33) Apply for PAR 14 230 Funding Number: PAR 14 230 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R33) Apply for PAR 14 231 Funding Number: PAR 14 231 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 15 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.